🔗 Visit the ClinicalTrials.gov page for NCT00894387
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. | Can J Cardiol | 2010 | 1.44 |
| 2 | Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. | JAMA | 2013 | 1.21 |
| 3 | Novel therapeutic targets for the treatment of heart failure. | Nat Rev Drug Discov | 2011 | 1.17 |
| 4 | Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT). | Eur J Heart Fail | 2010 | 1.06 |
| 5 | Targeting the renin-angiotensin-aldosterone system in heart failure. | Nat Rev Cardiol | 2013 | 0.95 |
| 6 | Role of aliskiren in blood pressure control and renoprotection. | Int J Nephrol Renovasc Dis | 2011 | 0.77 |